Clinical Trial Update: Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This is a Phase 1 trial update evaluating SB 11285 alone and in combination with atezolizumab in patients with advanced solid tumors, including melanoma and hea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Melanoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• SB 11285

Snippet

Sponsor: invoX Pharma Limited | Conditions: Melanoma, Head and Neck Squamous Cell Carcinoma | Phase 1 | Status: COMPLETED